Optimizing Storage Solutions For Allogeneic iPSCs

As the development of cell therapies evolved, optimizing the supply chain became increasingly crucial for maintaining cell viability, functionality, and therapeutic potential. Cell & Gene’s Chief Editor, Erin Harris, welcomed industry experts Pratik Jaluria, Ph.D., SVP of Process and Analytical Development at BlueRock Therapeutics; Bruno Marques, Ph.D., VP of Process and Product Development at Century Therapeutics; and Kate Rochlin, Ph.D., COO at IN8bio, as they discussed cutting-edge cryopreservation approaches designed to maximize the efficacy of cell therapies. This timely discussion explored the latest advancements in automation and storage solutions, with a particular focus on tailored cryopreservation techniques for induced pluripotent stem cells (iPSCs). The panel provided valuable insights into strategies that could enhance the long-term stability and clinical applicability of cellular products.

Available on-demand thanks to the support of Charter Medical.